Research Article

Different Approach on our Cells and the Use of CRISPR/Cas 9 Technology: Super Gene'ethic

Volume: 33 Number: 5 October 25, 2023
TR EN

Different Approach on our Cells and the Use of CRISPR/Cas 9 Technology: Super Gene'ethic

Abstract

Aims: CRISPR/Cas9, a revolutionary genome editing tool derived from a bacterial system, has transformed molecular biology research, enabling precise and versatile modifications to the genome. This study surveyed 300 participants, including instructors, second-year medical students, and patient relatives from Selcuk University Faculty of Medicine, to assess their knowledge, attitudes, and ethical perspectives on gene editing. Methods: A comprehensive survey was conducted, and the participants' demographics were correlated with their responses. Statistical analysis was performed using SPSS 22.0. Results: The survey revealed significant differences (p<0.05) in attitudes based on gender, age, and participation groups. The age group of 18-29 exhibited the highest participation rate (57.3%), while the age group of 60-65 had the lowest (1%). Approximately 50.3% of participants reported no prior knowledge of CRISPR/Cas9, and 64.3% were university graduates. Obtaining approval from ethics committees was considered crucial by 151 respondents for commencing CRISPR/Cas9 research. Interestingly, 63.3% showed eagerness for genetically modified plants and animals, while only 9% expressed interest in studies related to eternal youth. Additionally, 88% found gene editing studies conflicting with their beliefs. Conclusions: CRISPR/Cas9 holds great promise for biomedicine and healthcare but necessitates enhanced public awareness and informed decision-making. The study highlights the importance of promoting informed discussions on the ethical implications of CRISPR/Cas9 to address the concerns and perceptions of various demographics. These valuable insights contribute to the ongoing discourse on the impact of CRISPR/Cas9 on society.

Keywords

CRISPR/Cas9, Genetic manipulation, Ethics, Genome Editing, Medical Applications.

Supporting Institution

No funding was received by the author.

Project Number

--

Thanks

2010-2021 Yılları arasında çalıştığım Selçuk Üniversitesi Tıp fakültesine teşekkür ederim.

References

  1. Didovyk A, Borek B, Tsimring L, Hasty J. Transcriptional regulation with CRISPR-Cas9: principles, advances, and applications. Current Opinion in Biotechnology. 2016; 40(Supplement C):177-84.
  2. Singh V, Braddick D, Dhar PK Exploring the potential of genome editing CRISPR-Cas9 technology. Gene. 2017;599 (Supplement C):1-18.
  3. Knight S, Tjian R, Doudna J. Genomes In Focus: Development And Applıcatıons Of Crıspr-Cas9 Imagıng Technologıes. Angewandte Chemie International Edition. 2017:1-21.
  4. HÄYry M. Synthetic Biology and Ethics: Past, Present, and Future. Cambridge Quarterly of Healthcare Ethics. 2017;26(2):186-205.
  5. Baker B. The Ethics of Changing the Human Genome. BioScience. 2016;66(4):267-73.
  6. Turan I, Şimşek Ü, Aslan H. Eğitim Araştırmalarında Likert Ölçeği ve Likert-Tipi Soruların Kullanımı ve Analizi. 2015. 186-203 p.
  7. Levesque R. SPSS Programming and Data Management: A Guide for SPSS and SAS Users. Fourth ed. Chicago, IL: SPSS Inc.; 2007. 1-540 p.
  8. Zhou G, Duan Y, Ma G, Wu W, Hu Z, Chen N, et al. Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy. Investigative Ophthalmology & Visual Science. 2017;58(12):5361-7.
  9. Ceasar SA, Rajan V, Prykhozhij SV, Berman JN, Ignacimuthu S. Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9. Biochimica et Biophysica Acta (BBA)- Molecular Cell Research. 2016;1863(9):2333-44.
  10. Ishii T. The ethics of creating genetically modified children using genome editing. Current Opinion in Endocrinology, Diabetes, and Obesity. 2017;24 (6):418-23.
APA
Köksoy, H., Ameen Al Qadri, M. S., Karakaya, S., Bacak, P., Yüksel, E. S., Koçer, Ş., Kav, E., Demir, S., Demirel, E., Akkaya, H., Akmeşe, A. N., & Taşkaya, A. (2023). Different Approach on our Cells and the Use of CRISPR/Cas 9 Technology: Super Gene’ethic. Genel Tıp Dergisi, 33(5), 594-598. https://doi.org/10.54005/geneltip.1332161
AMA
1.Köksoy H, Ameen Al Qadri MS, Karakaya S, et al. Different Approach on our Cells and the Use of CRISPR/Cas 9 Technology: Super Gene’ethic. Genel Tıp Derg. 2023;33(5):594-598. doi:10.54005/geneltip.1332161
Chicago
Köksoy, Hale, Mohammed Saleh Ameen Al Qadri, Serap Karakaya, et al. 2023. “Different Approach on Our Cells and the Use of CRISPR Cas 9 Technology: Super Gene’ethic”. Genel Tıp Dergisi 33 (5): 594-98. https://doi.org/10.54005/geneltip.1332161.
EndNote
Köksoy H, Ameen Al Qadri MS, Karakaya S, Bacak P, Yüksel ES, Koçer Ş, Kav E, Demir S, Demirel E, Akkaya H, Akmeşe AN, Taşkaya A (October 1, 2023) Different Approach on our Cells and the Use of CRISPR/Cas 9 Technology: Super Gene’ethic. Genel Tıp Dergisi 33 5 594–598.
IEEE
[1]H. Köksoy et al., “Different Approach on our Cells and the Use of CRISPR/Cas 9 Technology: Super Gene’ethic”, Genel Tıp Derg, vol. 33, no. 5, pp. 594–598, Oct. 2023, doi: 10.54005/geneltip.1332161.
ISNAD
Köksoy, Hale - Ameen Al Qadri, Mohammed Saleh - Karakaya, Serap - Bacak, Pelin - Yüksel, Elif Senanur - Koçer, Şengül - Kav, Emine et al. “Different Approach on Our Cells and the Use of CRISPR Cas 9 Technology: Super Gene’ethic”. Genel Tıp Dergisi 33/5 (October 1, 2023): 594-598. https://doi.org/10.54005/geneltip.1332161.
JAMA
1.Köksoy H, Ameen Al Qadri MS, Karakaya S, Bacak P, Yüksel ES, Koçer Ş, Kav E, Demir S, Demirel E, Akkaya H, Akmeşe AN, Taşkaya A. Different Approach on our Cells and the Use of CRISPR/Cas 9 Technology: Super Gene’ethic. Genel Tıp Derg. 2023;33:594–598.
MLA
Köksoy, Hale, et al. “Different Approach on Our Cells and the Use of CRISPR Cas 9 Technology: Super Gene’ethic”. Genel Tıp Dergisi, vol. 33, no. 5, Oct. 2023, pp. 594-8, doi:10.54005/geneltip.1332161.
Vancouver
1.Hale Köksoy, Mohammed Saleh Ameen Al Qadri, Serap Karakaya, Pelin Bacak, Elif Senanur Yüksel, Şengül Koçer, Emine Kav, Sümeyra Demir, Ece Demirel, Himmet Akkaya, Ayşe Nur Akmeşe, Ayşenur Taşkaya. Different Approach on our Cells and the Use of CRISPR/Cas 9 Technology: Super Gene’ethic. Genel Tıp Derg. 2023 Oct. 1;33(5):594-8. doi:10.54005/geneltip.1332161